GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Cemex S.a.b. De C.v. (CX) [hlAlert]

Rating:
Equal Weight
CX
up 124.71 %

Cemex S.a.b. De C.v. (CX) rated Equal Weight with price target $7 by Barclays Capital

Posted on: Monday,  Jan 16, 2012  8:25 AM ET by Barclays Capital

Barclays Capital rated Equal Weight Cemex S.a.b. De C.v. (NYSE: CX) on 01/16/2012. Previously Barclays Capital rated Overweight Cemex S.a.b. De C.v. (NYSE:
CX) on 09/26/2011., when the stock price was $3.42. Since then, Cemex S.a.b. De C.v. has gained 124.72% as of 10/23/2015's recent price of $7.68.
If you would have followed the previous Barclays Capital's recommendation on CX, you would have gained 124.71% of your investment in 1488 days.

CEMEX, S.A.B. de C.V. (CEMEX) is a Mexico-based holding company of entities whose main activities are oriented to the construction industry, through the production, marketing, distribution and sale of cement, ready-mix concrete, aggregates and other construction materials. CEMEX is a global cement manufacturer with operations in North America, Europe, South America, Central America, the Caribbean, Africa, the Middle East, Australia and Asia. The Company, through its operating subsidiaries, is engaged in the production, distribution, marketing and sale of cement, ready-mix concrete, aggregates and clinker. As of December 31, 2008, the Company?s main cement production facilities were located in Mexico, the United States, Spain, the United Kingdom, Germany, Poland, Croatia, Latvia, Colombia, Costa Rica, the Dominican Republic, Panama, Nicaragua, Puerto Rico, Egypt, the Philippines and Thailand. On December 26, 2008, the Company sold its Canary Islands operations.

Barclays Capital has assembled a world-class, award-winning team of analysts covering, credit, commodities, economics, emerging markets, equities, fixed income, foreign exchange and market strategy. We provide in-depth analysis of companies and macro coverage across asset classes, markets and the world’s economies. We have a highly quantitative approach and our research is underpinned by sophisticated analytics. Combined, these provide clients with the tools and insights necessary for successful risk management and financing. Our research teams are based in many of the world’s major financial centres providing our clients with a globally integrated perspective across products and geographies.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
1/16/2012 8:25 AM Buy
None
5.50 6.72
as of 12/31/2012
1 Week up  1.54 %
1 Month up  10.89 %
3 Months up  18.48 %
1 YTD up  83.11 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
1/13/2012 12:25 PM Buy
None
5.38 6.72
9/26/2011 1:25 PM Buy
None
3.42 5.76

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy